-
-
Call more information
660-596-2224 -
The FDA has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1%, GlaxoSmithKline), a nonsteroidal anti-inflammatory drug (NSAID) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults. Voltaren Arthritis Pain becomes the first prescription-strength NSAID topical gel for arthritis pain to be available over the […]
Read MoreHarvard Business Review Author: Adia Harvey Wingfield Grieving families, social distancing, economic disruption: In many respects, coronavirus has changed the world. But it also has exposed the startlingly consistent toll that catastrophe exacts from black communities. The old adage that “when white America catches a cold, black America gets pneumonia” has become a chilling reality. […]
Read MoreMedical News Today Trigeminy is an abnormal heart rhythm that causes an extra heartbeat. Specifically, the condition causes an abnormal heart rhythm to occur every third heartbeat. Trigeminy can be harmless. In many cases, it causes mild or no symptoms. However, it can also indicate the presence of something more serious, such as heart disease, or […]
Read MoreAUTHORS: Clunies-Ross, Natasha MBBS, FRCA et al Anesthesia & Analgesia: March 2020 BACKGROUND: QT interval prolongation is associated with torsade de pointes but remains a poor predictor of drug torsadogenicity. Increased transmural dispersion of myocardial repolarization (TDR), measured as the time interval between the peak and end of the T wave (Tp-e), is a more […]
Read MoreBy Nancy Shaw DG News Radiofrequency therapy, including thermal, pulsed, and cooled methods, provides significant improvement in osteoarthritic and chronic knee pain for up to 3 months, according to a study presented here at the 2020 Annual Meeting of the American Academy of Pain Medicine (AAPM). “Radiofrequency therapy significantly reduces osteoarthritic knee pain for at […]
Read MoreThe FDA approved the New Drug Application for a meloxicam injection (Anjeso, Baudax Bio), which is indicated for managing moderate to severe pain, alone or in combination with other non–nonsteroidal anti-inflammatory drug (NSAID) analgesics, according to a press release from the company. The treatment is administered as a once-daily IV bolus push. It is the […]
Read MoreAuthor: Denise Baez Current smokers and people with chronic obstructive pulmonary disease (COPD) who contract coronavirus disease 2019 (COVID-19) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a study published in PLOS ONE. Jaber Alqahtani, University College London, London, United Kingdom, and colleagues scrutinised data from 15 studies comprising […]
Read MoreDG Alerts A clinical risk score can help clinicians identify patients with coronavirus disease 2019 (COVID-19) who may subsequently develop critical illness at the time of hospital admission, according to a study published in JAMA Internal Medicine. The tool, dubbed COVID-GRAM, uses 10 variables that are generally readily available at hospital admission to predict critical illness. […]
Read MoreBy Nancy Shaw DG News Treatment of chronic pain with spinal cord stimulation (SCS) therapy is linked to significant improvements in sleep quality, according to a study presented here at the 2020 Annual Meeting of the American Academy of Pain Medicine (AAPM). “Marked improvements in sleep quality were observed in the EVOKE study, with greater […]
Read MoreAuthors Judy George, Shannon Firth, and Kristina Fiore, MedPage Today Staff — Nearly 5% of those who responded to a bi-weekly MedPage Today survey have or had the disease Of 763 respondents in a MedPage Today survey — 86% of whom were physicians — 4.91% reported they had or currently have COVID-19. The findings come from […]
Read More